Aerohive Networks
HIVE
$4.90
+15.02%
HIVE Digital Technologies Ltd. is a company focused on providing infrastructure solutions within the blockchain industry, primarily through the mining and sale of digital currencies such as Bitcoin. It operates as a publicly-traded cryptocurrency miner, distinguishing itself through its geographically diversified operations across Canada, Sweden, Iceland, Switzerland, and Bermuda. The current investor narrative is dominated by the volatile nature of the crypto mining sector, with recent industry news highlighting a potential strategic pivot by peers towards high-margin AI infrastructure, placing HIVE at the center of debates about its core business model's sustainability and adaptability in the face of fluctuating Bitcoin prices and evolving energy-intensive compute markets.…
HIVE
Aerohive Networks
$4.90
Related headlines
Investment Opinion: Should I buy HIVE Today?
Rating: Hold. The core thesis is that HIVE is a highly speculative, momentum-driven instrument with catastrophic fundamentals, suitable only for risk-tolerant traders betting on continued sector momentum, not for investors seeking a sustainable business.
Supporting evidence includes the stock's explosive 110.89% 3-month return and low PS ratio of 1.44x, which provide a superficial allure. However, this is overwhelmingly countered by a trailing EPS of -$0.35, negative margins across the board, and an extreme beta of 3.719 that signals enormous volatility risk. The lack of a clear analyst price target or consensus further muddies the valuation picture, leaving no reliable anchor for fair value.
The thesis would upgrade to a speculative Buy only if the company announces a credible, funded strategic pivot (e.g., to AI infrastructure) that promises a path to positive margins, or if Bitcoin enters a sustained bull market that lifts all miners. It would downgrade to a Sell if quarterly results show accelerating cash burn, liquidity deteriorates (current ratio below 1.0), or the stock breaks below its 52-week low of $1.60. Relative to its own broken fundamentals, the stock is overvalued; relative to its sector's momentum, it may appear cheap. This paradox defines the Hold rating.
Sign up to view all
HIVE 12-Month Price Forecast
The AI assessment is bearish due to the irreconcilable gap between HIVE's powerful price momentum and its fundamentally broken business model. While technicals suggest upside, the severe negative margins and cash burn present a tangible survival risk that momentum cannot permanently offset. Confidence is medium (not high) because in a speculative mania, broken fundamentals can be ignored for longer than expected. The stance would upgrade to neutral only upon clear evidence of a viable path to profitability, such as sustained positive gross margins. It would remain bearish until such evidence materializes, as the current valuation of 1.44x PS is not low enough to compensate for the existential risks presented by the income statement.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aerohive Networks's 12-month outlook, with a consensus price target around $6.37 and implied upside of +30.0% versus the current price.
Average Target
$6.37
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$4 - $6
Analyst target range
Analyst coverage for HIVE is limited, with only 3 analysts providing estimates, indicating this is a small-cap stock with constrained institutional interest, which can lead to higher volatility and less efficient price discovery. The available data provides consensus estimates for revenue and EPS but does not include a consensus price target, Buy/Hold/Sell distribution, or a target price range, which are necessary to calculate implied upside/downside and gauge sentiment. The estimated revenue range for the period is wide, from $452.2 million to $558.7 million, with an average of $499.3 million, while the estimated EPS range is from -$0.53 to -$0.40, averaging -$0.46. This wide range in estimates, particularly for profitability, signals high uncertainty among the few covering analysts regarding the company's fundamental performance, making it difficult to derive a clear signal on valuation or future catalysts from the analyst community.
Bulls vs Bears: HIVE Investment Factors
The investment debate for HIVE is a classic clash between powerful momentum and deeply flawed fundamentals. The bull case is driven by explosive technical performance and a low PS ratio, suggesting the market may be undervaluing its sector exposure. The bear case is anchored in severe, sustained unprofitability and extreme volatility that questions the viability of the underlying business. Currently, the bear side holds stronger evidence due to the concrete, negative financial metrics that directly challenge the company's survival without external support. The single most important tension is whether HIVE's current revenue-generating model can ever achieve profitability, or if it must successfully pivot its infrastructure—as peers are attempting—to a more sustainable compute market like AI. The resolution of this strategic question will ultimately determine the stock's fate.
Bullish
- Explosive Price Momentum: HIVE has delivered a 142.05% return over the past year and a 110.89% surge over the past three months, dramatically outperforming the SPY. This powerful uptrend, combined with the stock trading at only 54.3% of its 52-week high, suggests significant room for further appreciation before hitting major resistance.
- Low Price-to-Sales Valuation: The stock trades at a trailing PS ratio of 1.44x, which is a low absolute multiple for a company in a high-growth thematic sector. This modest valuation provides a margin of safety and could attract value-oriented investors if the company's revenue trajectory improves.
- Strategic Sector Positioning: HIVE operates in the blockchain infrastructure sector, a market with long-term growth potential tied to digital asset adoption. Its geographically diversified operations across Canada, Sweden, and Iceland provide operational resilience, a key factor in the volatile crypto mining industry.
- Moderate Financial Leverage: With a debt-to-equity ratio of 0.13, HIVE's balance sheet is not overburdened by debt. This provides financial flexibility and reduces bankruptcy risk, which is crucial for a company currently operating at a loss.
Bearish
- Severe and Sustained Unprofitability: The company is fundamentally unprofitable with a trailing EPS of -$0.35, a gross margin of -21.0%, and a net margin of -49.8%. These figures indicate the core mining business is burning cash, with no clear path to profitability from current operations.
- Extreme Volatility and Drawdown Risk: HIVE's beta of 3.719 means it is approximately 272% more volatile than the broader market. This is evidenced by a maximum drawdown of -74.86%, indicating the stock is prone to severe, rapid declines, making it a high-risk holding for most investors.
- Business Model Sustainability Concerns: Recent industry news highlights a strategic pivot by peers like IREN from volatile crypto mining to high-margin AI infrastructure. HIVE's reliance on Bitcoin mining, coupled with negative margins, raises existential questions about its long-term business model adaptability and competitive positioning.
- Weak Liquidity and Analyst Uncertainty: A current ratio of 1.10 indicates borderline ability to cover short-term obligations, a concern for a cash-burning business. Furthermore, limited analyst coverage (only 3 analysts) and a wide EPS estimate range (-$0.53 to -$0.40) signal high uncertainty and poor visibility into future performance.
HIVE Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 142.05% over the past year, but is currently trading well below its 52-week high, at approximately 54.3% of its 52-week range ($1.60 low to $7.84 high). This positioning, significantly off the highs, suggests the recent rally has room to run before encountering major overhead resistance, though it remains a highly volatile asset as indicated by its extreme beta of 3.719. Recent momentum has been exceptionally strong but shows signs of volatility, with a 27.16% gain over the past month and a 110.89% surge over the past three months, significantly outpacing the SPY's gains of 0.74% and 15.14%, respectively, over the same periods. This explosive short-term performance confirms the longer-term bullish trend, though the stock's inherent volatility warns of potential sharp pullbacks. Key technical levels are clearly defined, with major support at the 52-week low of $1.60 and resistance at the 52-week high of $7.84. A sustained breakout above $7.84 would signal a resumption of the prior bull market, while a breakdown below $1.60 would indicate a failure of the current recovery. The stock's beta of 3.719 means it is approximately 272% more volatile than the broader market, a critical factor for risk management given its 74.86% maximum drawdown.
Beta
3.72
3.72x market volatility
Max Drawdown
-74.9%
Largest decline past year
52-Week Range
$2-$8
Price range past year
Annual Return
+188.2%
Cumulative gain past year
| Period | HIVE Return | S&P 500 |
|---|---|---|
| 1m | +20.4% | -0.2% |
| 3m | +139.0% | +14.0% |
| 6m | +71.9% | +7.8% |
| 1y | +188.2% | +25.3% |
| ytd | +79.5% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HIVE Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate data are not available in the provided dataset. However, analyst estimates point to expected annual revenue of approximately $499.3 million, providing a forward-looking benchmark, though the trend of this estimate (accelerating or decelerating) cannot be determined. The company is fundamentally unprofitable, with a trailing EPS of -$0.35 and deeply negative gross and net margins of -21.0% and -49.8%, respectively. The operating margin of -40.2% further confirms significant operational losses, indicating the business is burning cash on its core mining activities with no immediate path to profitability suggested by these figures. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.13, but weak liquidity evidenced by a current ratio of 1.10, which is borderline for covering short-term obligations. The negative profitability metrics (ROA of -11.60%, ROE of -28.04%) and lack of cash flow data preclude a standard assessment of internal funding capability, but the negative margins strongly imply dependence on external financing or asset sales to fund ongoing operations.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HIVE Overvalued?
Given the company's negative net income and EPS, the primary valuation metric selected is the Price-to-Sales (PS) ratio. HIVE trades at a trailing PS ratio of 1.44x, while its Enterprise Value-to-Sales (EV/Sales) is higher at 3.78x, reflecting the inclusion of debt in its capital structure; the absence of a forward PS ratio limits growth expectation analysis. Peer comparison is not possible as industry average valuation multiples were not provided in the dataset. Without this benchmark, we cannot quantify whether the PS ratio of 1.44x represents a premium or discount to the sector, nor assess its justification relative to growth or competitive position. Historical context is also unavailable due to missing historical ratios data. Therefore, we cannot determine if the current PS ratio is near the top or bottom of its own historical range, which would help interpret whether the market is pricing in optimistic or pessimistic expectations for the company's future sales trajectory.
PE
-2.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on HIVE's cash-burning operations. With gross, operating, and net margins all deeply negative (-21.0%, -40.2%, and -49.8% respectively), the company is fundamentally unprofitable. This necessitates reliance on external financing or asset sales to fund operations, a precarious position exacerbated by weak liquidity (current ratio of 1.10). The wide range in analyst EPS estimates (-$0.53 to -$0.40) underscores the high uncertainty around the pace of this cash burn and the company's ability to stem losses.
Market & Competitive Risks are amplified by HIVE's extreme beta of 3.719, making it a hyper-volatile instrument highly sensitive to sector sentiment and Bitcoin price swings. The stock trades at a significant discount to its 52-week high, but the lack of peer valuation data makes it difficult to assess if its PS ratio of 1.44x is justified. A critical emerging risk is competitive disruption, as evidenced by news of peers like IREN pivoting from Bitcoin mining to AI infrastructure, potentially leaving HIVE behind in a lower-margin, more volatile business if it cannot adapt.
Worst-Case Scenario involves a sustained downturn in Bitcoin prices combined with an inability to secure financing. This would accelerate cash burn, forcing a dilutive equity raise or debt restructuring at unfavorable terms. Operational cuts could further impair revenue. In this adverse scenario, the stock could realistically retest its 52-week low of $1.60, representing a downside of approximately -62% from the recent close of $4.26. The historical maximum drawdown of -74.86% provides a precedent for losses of this magnitude.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The company is burning cash with a -49.8% net margin and borderline liquidity (current ratio 1.10), risking a funding crisis. 2) Volatility Risk: A beta of 3.719 means HIVE's price is prone to swings over 3x the market's moves, as seen in its 74.86% max drawdown. 3) Business Model Risk: The core Bitcoin mining operation is unprofitable, and the industry is seeing peers pivot to AI, threatening HIVE's long-term relevance. 4) Market Risk: Revenue is directly tied to the highly volatile price of Bitcoin, introducing massive exogenous uncertainty.
The 12-month forecast for HIVE is a wide range of outcomes with high uncertainty. The base case (50% probability) sees the stock trading between $2.50 and $4.50, driven by ongoing volatility without fundamental resolution. The bull case (25% probability) targets $6.50 to $7.84, requiring a Bitcoin bull market and a successful strategic shift. The bear case (25% probability) warns of a drop to $1.60-$2.20 if Bitcoin weakens and cash burn accelerates. The base case is most likely, as it reflects the continuation of current conditions: powerful but erratic momentum underpinned by persistently poor fundamentals. The key assumption is that Bitcoin does not enter a sustained new bull or bear trend.
HIVE's valuation is paradoxical. On a Price-to-Sales (PS) basis at 1.44x, it appears cheap relative to many high-growth tech stocks. However, this multiple is applied to a business with deeply negative margins, meaning sales are generated at a significant loss. The Enterprise Value-to-Sales ratio of 3.78x is higher, reflecting its capital structure. Without profitable peers for comparison, the true 'fair value' is unclear. The market is effectively valuing HIVE as a call option on Bitcoin's future and a potential business model pivot, not on its current earnings power. Given the catastrophic profitability, the stock is overvalued on any earnings-based metric but may be relatively undervalued within the volatile crypto miner sector.
HIVE is not a good stock to buy for most investors. It is a highly speculative instrument suitable only for traders who understand and can tolerate extreme risk. The 142% annual return is attractive but comes with a 74.86% max drawdown and a beta of 3.719, meaning violent swings are the norm. The company is fundamentally unprofitable with a -49.8% net margin, making it a 'story stock' reliant on Bitcoin's price and sector sentiment. It could be a tactical trade for those with strong conviction in a near-term crypto rally, but it is a poor choice for a long-term portfolio holding.
HIVE is suitable only for short-term trading or tactical speculation, not for long-term investment. The company lacks the earnings visibility, profitability, and stable business model required for a long-term holding. Its extreme beta of 3.719 and 74.86% drawdown potential make it far too volatile for a buy-and-hold strategy. Furthermore, it pays no dividend. The investment horizon should be measured in weeks or months, aligned with trading views on Bitcoin's price direction. A minimum holding period is not applicable; it is a trading vehicle that requires active risk management and a readiness to exit positions quickly.